Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.51)
# 1,078
Out of 5,082 analysts
65
Total ratings
60.9%
Success rate
26.4%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFLY Butterfly Network | Initiated Coverage: Buy | $15 | $7.38 | +103.25% | 1 | Sep 29, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 → $27 | $18.93 | +42.63% | 4 | Sep 2, 2026 | |
| NTRA Natera | Reiterated: Buy | $300 → $360 | $410.82 | -12.37% | 9 | Aug 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $180 | $149.83 | +20.14% | 6 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $40 → $54 | $71.30 | -24.26% | 9 | Aug 4, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $410 → $425 | $398.29 | +6.71% | 10 | Jul 27, 2026 | |
| RGEN Repligen | Reiterated: Buy | $140 → $160 | $175.80 | -8.99% | 9 | Jul 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $118 → $90 | $69.73 | +29.07% | 6 | Jul 6, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $72.60 | -31.13% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $78.56 | -13.44% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $90 | $178.06 | -49.46% | 4 | Oct 30, 2025 |
Butterfly Network
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $7.38
Upside: +103.25%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $20 → $27
Current: $18.93
Upside: +42.63%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $300 → $360
Current: $410.82
Upside: -12.37%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $180
Current: $149.83
Upside: +20.14%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $40 → $54
Current: $71.30
Upside: -24.26%
West Pharmaceutical Services
Jul 27, 2026
Reiterated: Buy
Price Target: $410 → $425
Current: $398.29
Upside: +6.71%
Repligen
Jul 6, 2026
Reiterated: Buy
Price Target: $140 → $160
Current: $175.80
Upside: -8.99%
TransMedics Group
Jul 6, 2026
Reiterated: Buy
Price Target: $118 → $90
Current: $69.73
Upside: +29.07%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $72.60
Upside: -31.13%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $78.56
Upside: -13.44%
Oct 30, 2025
Reiterated: Buy
Price Target: $68 → $90
Current: $178.06
Upside: -49.46%